EP 1353655 A2 20031022 - METHOD OF TREATMENT OF NEURODEGENERATIVE DISORDERS USING PENTAAZA-MACROCYCLIC LIGAND COMPLEXES
Title (en)
METHOD OF TREATMENT OF NEURODEGENERATIVE DISORDERS USING PENTAAZA-MACROCYCLIC LIGAND COMPLEXES
Title (de)
VERFAHREN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN MIT PENTAAZA-MAKROZYKLISCHEN LIGANDKOMPLEXEN
Title (fr)
METHODE DE TRAITEMENT DE TROUBLES NEURODEGENERATIFS
Publication
Application
Priority
- US 0202108 W 20020123
- US 26449301 P 20010126
Abstract (en)
[origin: WO02058686A2] The present invention relates to pharmaceutical compositions and methods using such compositions for the treatment of neurodegenerative disorders. Such compositions contain a catalyst for the dismutation of superoxide, including superoxide dismutase enzyme (SOD) and low molecular weight organic ligand derived metal complexes that function as mimics of the enzyme (SOD mimetics or SODms).
IPC 1-7
IPC 8 full level
A61K 31/555 (2006.01); A61P 25/28 (2006.01)
CPC (source: EP)
A61K 31/555 (2013.01); A61P 25/28 (2017.12)
Citation (search report)
See references of WO 02058686A2
Citation (examination)
- BEERS M.H.; BERKOW R.: "The Merck Manual of Diagnosis and Therapy, seventeenth Edition", 1999, MERCK RESEARCH LABORATORIES, WHITEHOUSE STATION, N.J.
- ALBERS ET AL: "Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease", J. NEURAL TRANSM. SUPPL., vol. 59, 2000, pages 133 - 154, XP008046819
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02058686 A2 20020801; WO 02058686 A3 20030206; AU 2002236861 A1 20020806; EP 1353655 A2 20031022
DOCDB simple family (application)
US 0202108 W 20020123; AU 2002236861 A 20020123; EP 02703228 A 20020123